EXONATE LIMITED

Active Cambridge

Manufacture of basic pharmaceutical products

9 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical products
E

EXONATE LIMITED

Manufacture of basic pharmaceutical products

Founded 5 Dec 2013 Active Cambridge, England 9 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical products
Accounts Submitted 31 Dec 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 16 Jan 2026 Next due 19 Dec 2026 6 months remaining
Net assets £-6M £2M 2024 year on year
Total assets £1M £1M 2024 year on year
Total Liabilities £7M £310K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Wtl Moorfield Road Duxford Cambridge Cambridgeshire CB22 4PS England

Telephone

0800 000 0000

Website

www.example.com

Full company profile for EXONATE LIMITED (08803638), an active life sciences and medical technology company based in Cambridge, England. Incorporated 5 Dec 2013. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£1.11M

Decreased by £901.04k (-45%)

Net Assets

-£5.61M

Decreased by £1.63M (-41%)

Total Liabilities

£6.83M

Increased by £309.65k (+5%)

Turnover

N/A

Employees

9

Decreased by 5 (-36%)

Debt Ratio

559%

Increased by 302 (+118%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 5

Investors (12)

Investor NameInvestor SinceParticipating Rounds
Investor 1Apr 2014Seed
Investor 2Apr 2014Seed
Investor 3Oct 2015Seed

Share Capital

Share Capital

Share allotments and capital structure

7 Allotments 24,042 Shares £1.70m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
5 Nov 2021100£1£0.01
22 Jul 2021350£3.5£0.01
27 Mar 20192,468£200k£81
14 Jan 20191,100£12k£11
25 Sept 201811,823£958k£81

Officers

Officers

3 active
Status
Catherine Susan Minshull-beechDirectorBritishUnited Kingdom6930 Jan 2014Active
Christopher John TorranceDirectorBritishUnited Kingdom5728 Sept 2015Active
Sunil Rajen ShahDirectorBritishUnited Kingdom5310 Jun 2014Active

Shareholders

Shareholders (67)

Angel Cofund
11.2%
9,224
The University Of Nottingham
10.4%
8,614

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
10 Mar 2026OfficersAppointment of Mr Phil Bates as director on 5 Mar 2026
18 Feb 2026OfficersTermination of Steven James Harper as director on 13 Feb 2026
16 Jan 2026Confirmation StatementConfirmation statement made on 5 Dec 2025 with updates
31 Dec 2025AccountsAnnual accounts made up to 31 Dec 2024
20 Dec 2024Confirmation StatementConfirmation statement made on 5 Dec 2024 with updates
10 Mar 2026 Officers

Appointment of Mr Phil Bates as director on 5 Mar 2026

18 Feb 2026 Officers

Termination of Steven James Harper as director on 13 Feb 2026

16 Jan 2026 Confirmation Statement

Confirmation statement made on 5 Dec 2025 with updates

31 Dec 2025 Accounts

Annual accounts made up to 31 Dec 2024

20 Dec 2024 Confirmation Statement

Confirmation statement made on 5 Dec 2024 with updates

Recent Activity

Latest Activity

Appointment of Mr Phil Bates as director on 5 Mar 2026

2 months ago on 10 Mar 2026

Termination of Steven James Harper as director on 13 Feb 2026

3 months ago on 18 Feb 2026

Confirmation statement made on 5 Dec 2025 with updates

4 months ago on 16 Jan 2026

Annual accounts made up to 31 Dec 2024

5 months ago on 31 Dec 2025

Confirmation statement made on 5 Dec 2024 with updates

1 years ago on 20 Dec 2024